Position in AMGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$6,106,067
+$235,098 QoQ
Shares Held
16,862
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#741
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BURNEY CO/ holds $61,483,180 across 10 Drug Manufacturers - General names. AMGN ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
24,397 | $29,262,496 | |
| 2 | ABBV |
AbbVie Inc.
|
45,639 | $11,484,597 | |
| 3 | JNJ |
Johnson & Johnson
|
28,586 | $7,259,986 | |
| 4 | AMGN |
Amgen Inc
This page
|
16,862 | $6,106,067 | |
| 5 | MRK |
Merck & Co., Inc.
|
16,615 | $2,135,027 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
25,296 | $1,457,555 | |
| 7 | NVO |
Novo Nordisk A S
|
25,368 | $1,216,141 | |
| 8 | PFE |
Pfizer Inc
|
38,365 | $923,829 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,106,067 | 16,862 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $5,870,969 | 16,686 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $6,441,460 | 19,680 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $5,685,483 | 20,147 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,634,457 | 20,180 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $5,926,615 | 19,023 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,016,016 | 19,245 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $6,417,134 | 19,916 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $6,288,368 | 20,126 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $5,823,157 | 20,481 | Shares | Sole | 2024-05-22 | |
| 2023-12-31 | $6,179,469 | 21,455 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $5,833,973 | 21,707 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $5,216,137 | 23,494 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,003,255 | 28,969 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $8,939,740 | 34,038 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $8,411,026 | 37,316 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $11,843,600 | 48,679 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,459,366 | 47,388 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $10,758,515 | 47,822 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,491,300 | 49,336 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,254,043 | 50,273 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $12,732,602 | 51,174 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $11,584,749 | 50,386 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $13,104,489 | 51,560 | Shares | Sole | 2020-12-14 | |
| 2020-06-30 | $12,429,822 | 52,700 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $10,828,417 | 53,413 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||